Helping the injured since 1983

Contact us at (713) 352-7071 to schedule a FREE consultation today.

Get Help NOW!


Chemotherapy: A valuable uterine cancer treatment

Posted on Friday, August 7th, 2015 at 2:50 pm by Williams Hart   

Patients whose endometrial cancer has been diagnosed and treated early on have a better chance of survival and cure. In fact, diagnosing and treating earlier stages of endometrial cancer (stage 0 to stage 2) provide a 5-year survival rate of 69% to 90%. So, at the early stages at least, there are a majority of good outcomes for endometrial cancer patients.

One of the most effective treatment options for endometrial cancer is chemotherapy. Chemotherapy involves the use of a combination of drugs to fight against cancer. Because these cancer-fighting drugs reach throughout the body, chemotherapy is an effective treatment for endometrial cancer that has already spread beyond the uterus and the pelvic area.

Hysterectomies utilizing power morcellators have been found to increase the risk of spreading undetected uterine cancer. If you have been harmed by this device, you might be eligible to file a claim against the manufacturer of this product. To learn more about seeking compensation, consult with our power morcellator legal team at Williams Hart by calling (713) 352-7071 today.

Radiation therapy for uterine cancer

Posted on Friday, August 7th, 2015 at 1:41 pm by Williams Hart   

Uterine cancer is considered among the deadliest types of cancer affecting women. In fact, the American Cancer Society predicts that this year, about 10,170 women will die from uterine cancer complications. The agency also said approximately 54,870 women will be diagnosed with the disease.

One of the most common endometrial cancer treatments is radiation therapy. Radiation therapy involves the use of radiation to kill cancer cells and can be performed using a machine outside the body (external beam radiation), or a radiation-filled device placed inside the body (brachytherapy). However, people undergoing radiation therapy for uterine cancer may experience some side-effects, such as rectal bleeding, bladder irritation, incontinence, and sexual problems.

Some studies showed that the risk of uterine cancer is higher among women who have undergone laparoscopic procedure involving a power morcellator. If this device has caused you harm, you might be eligible to seek compensation from the manufacturer involved. Speak with our team at Williams Hart by calling (713) 352-7071 today to learn more about filing a lawsuit.

Contraceptive pills and pregnancy lower uterine cancer risk – study

Posted on Friday, July 17th, 2015 at 1:26 pm by Williams Hart   

Researchers at the University of Melbourne found that women with Lynch syndrome have a lower risk of uterine cancer if they are taking hormonal contraceptives or have been pregnant before, Health Canal reported on July 7.

The study, which involved 1,128 women with a gene mutation that causes Lynch syndrome, found that women who had one child were 60% less likely to have uterine cancer compared to those who had none. The risk became even lower for women with more than one child. On the other hand, women who took hormonal contraceptives for at least a year decreased their risk of uterine cancer by 50%.

Lynch syndrome is a genetic disease that increases a woman’s risk of certain types of cancer, including uterine cancer. One in 1,000 women has a Lynch syndrome-causing gene mutation.

Apart from Lynch syndrome, the use of a power morcellator during hysterectomies also increases a woman’s risk of uterine cancer. Speak with an attorney at Williams Hart by calling (713) 352-7071 to learn more about how to hold the maker of this dangerous medical device accountable for the harm it has caused you.

Postmenopausal bleeding a sign of uterine cancer

Posted on Wednesday, June 17th, 2015 at 3:17 pm by Williams Hart   

Postmenopausal bleeding, or menstrual bleeding after more than one year of finishing menopause, can indicate serious medical conditions. One of these conditions is uterine cancer, which according to the Centers for Disease Control and Prevention is the 4th most common cancer among American women.

Apart from bleeding during menopause, other symptoms of uterine cancer include pelvic pain, painful sexual intercourse, and watery vaginal discharge that is sometimes tinged with blood. If you are going through menopause and have experienced bleeding, or even slight spotting, consult with your obstetrician immediately to learn more about your risk of uterine cancer.

You may also be at risk of uterine cancer if you have undergone a laparoscopic procedure involving a power morcellator. If you believe your diagnosis of uterine cancer has resulted from this medical device, a lawyer at Williams Hart might be able to guide you through the process of seeking compensation through a lawsuit. Call us at (713) 352-7071 today.

Can hormone replacement therapy increase risk of endometrial cancer?

Posted on Wednesday, June 17th, 2015 at 3:10 pm by Williams Hart   

Endometrial cancer happens when cancerous cells grow and spread in the endometrium, or the inside lining of the uterus. Women who are going through menopause, are obese, or have never been pregnant are all at risk of endometrial cancer. Additionally, women who are undergoing hormone replacement therapy (HRT) to fight against symptoms of menopause are considered more prone to this disease.

One factor that could increase your risk of endometrial cancer is the shift in the balance of two female hormones, progesterone and estrogen. The American Cancer Society stated that taking estrogen without progesterone during HRT increases a woman’s risk of endometrial cancer. As such, it is important to ask your doctor about your endometrial cancer risk before undergoing any type of HRT.

Unfortunately, women who undergo a laparoscopic procedure using a power morcellator are also at risk of endometrial cancer. Consult with our legal team at Williams Hart by calling (713) 352-7071 to learn more about taking legal action after being hurt by this dangerous medical device.

FBI investigates Johnson & Johnson over power morcellators

Posted on Thursday, May 28th, 2015 at 10:43 am by Williams Hart   

The FBI is currently investigating what, exactly, Johnson & Johnson knew about their laparoscopic power morcellator before it was released and while it was on the market, according to a Wall Street Journal article on May 27.

Power morcellators, often used in hysterectomies, are designed to cut up fibroids in the uterus which are then extracted through small incisions. Unfortunately, however, these devices have resulted in the spread of previously undetected uterine cancer in many women. J & J recalled the product last year but has been receiving alerts about its dangers for at least the past nine years.

A former pathologist contacted the company in 2006 to express his concerns that use of the device would spread cancerous cells, thus further threatening a patient’s health. A J & J spokesperson said that after this communication, an additional warning was added to the instructions, explaining that malignant tissue may be spread through its use.

A physician’s assistant in California accumulated a list of women, including her, whose cancers worsened after the device was used in a medical procedure. The list consists of 386 names. This woman, along with the retired pathologists and others who have spoken out against the power morcellator, has been contacted by the FBI as part of its investigation.

The attorneys of Williams Hart are dedicated to representing those whose health has been affected by the use of power morcellators. Call us at (713) 352-7071 today to learn more about holding the responsible parties accountable.

Soft drinks may increase the risk of endometrial cancer

Posted on Tuesday, May 26th, 2015 at 10:45 am by Williams Hart   

Older age, obesity, early start of menstruation, and hormone therapy are among the many risk factors associated with uterine cancer. But apart from these, a recent study published in the Journal Cancer Epidemiology, Biomarkers & Prevention revealed that soft drinks may also increase your risk of developing this life-threatening disease.

In a study that looked into 23,000 post-menopausal women, individuals who consumed sugar-sweetened drinks were 72% more at risk of uterine cancer. Experts believe sugar-sweetened beverages increase the level of estrogen in the body. Because post-menopausal women are not able to shed their endometrial lining regularly, increased estrogen level may cause their lining to thicken, thereby increasing their risk of uterine cancer.

Unfortunately, these are not the only risk factors associated with endometrial cancer. Power morcellators, for instance, may cause the spread of undetected cancer in the uterus during laparoscopic procedures. To learn more about taking legal action after being harmed by this medical device, consult with our legal team at Williams Hart by calling (713) 352-7071 today.

Health insurers want tighter approval and monitoring of medical devices

Posted on Monday, April 27th, 2015 at 10:42 am by Williams Hart   

In a letter addressed to Sen. Bob Casey on April 14, a large group of health insurers called for tougher approval and monitoring of medical devices, according to a report by The Wall Street Journal.

The demand was in light of a growing number of uterine cancer diagnoses associated with laparoscopic procedures involving power morcellators. Some studies have shown using the medical device may cause undetected cancer tissues to spread in the uterus. The health insurance group America’s Health Insurance Plans said the U.S. Food and Drug Administration (FDA) needs to amend its 510 (k) process–a pre-market process that aims to prove that a medical device is as safe and as effective as a device already approved for the market.

A uterine cancer diagnosis can be frightening and overwhelming. If you believe your health condition has resulted from a power morcellator, the legal team at Williams Hart might be able to help you file a claim against the manufacturer involved. Call us at (713) 352-7071 to learn about your legal options today.

How a power morcellator could spread cancer

Posted on Monday, January 5th, 2015 at 9:54 am by Williams Hart   

Since the U.S Food and Drug Administration’s (FDA) warning about its association with uterine cancer in April 2014, power morcellators have been the subject of fierce criticism among many uterine cancer advocates and women who have recently been diagnosed with the disease after undergoing a power morcellation procedure.

To understand clearly the risk of uterine cancer, here is a quick guide on how a power morcellator typically works:

  1. A small incision in the abdomen is made where the power morcellator’s hollow tube, blade and pincers will be inserted.
  2. The pincers will grasp the uterine fibroid and pull it towards the device’s shaft.
  3. A rotating blade in the shaft of the tool will break the mass into pieces. During this process, undetected cancer tissues may also be morcellated.
  4. Morcellated tissues are captured by the device’s hollow tube that is connected to a vacuum source. In some instances, morcellated cancer tissues are left behind, spreading these cancerous tissues.

If you believe your health has been severely compromised after undergoing a laparoscopic procedure involving power morcellators, a lawyer at Williams Hart might be able to help you seek the compensation you believe you deserve. Call us at (713) 352-7071 for a free and non-obligatory assessment of your situation.

Have you or a loved one been injured in an accident?

Contact us today at (713) 352-7071 to get a free, confidential case evaluation.